BCAX Bicara Therapeutics Inc. - Common Stock
$26,17
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 11, 2026
Rango 52S
$10–$31
77% of range
Calificación del Analista
BUY
21 analysts
Precio Objetivo
$33
+28% upside
P/E (TTM)
-12.0
ROE
-33.0%
Margen de Beneficio Neto
—
BCAX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$26.17
Capitalización Bursátil
$1.72B
P/E (TTM)
-12.0
BPA (TTM)
$-2.52
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-33.0%
Deuda/Capital
—
Rango 52S
$10 – $31
BCAX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-2.52
2023-12-31
→
2025-12-31
Flujo de caja libre
$-107M
2024-12-31
→
2025-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
BCAX
Mediana de Pares
P/E (TTM)
-12.0
—
P/B (P/C)
4.3
2.7
Price / FCF (Precio / FCF)
-16.0
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
BCAX
Mediana de Pares
ROA
-29.3%
-43.1%
ROE
-33.0%
-49.0%
ROIC
-38.8%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
BCAX
Mediana de Pares
Current Ratio (Ratio corriente)
14.6
9.0
Quick Ratio (Ratio Rápido)
14.3
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
BCAX
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
BCAX
Mediana de Pares
BCAX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
21 analistas
- Compra fuerte 7 33,3%
- Compra 10 47,6%
- Mantener 4 19,0%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
13 analistas · 2026-08-19
Mediana
$34.00
Ahora
$26.17
Mín
$20.00
Máx
$45.00
Objetivo mediano
$34.00
+29,9%
Objetivo medio
$33.38
+27,6%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-0.07%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.82 | $-0.85 | 0.03% |
| 31 de marzo de 2026 | $-0.93 | $-0.77 | -0.16% |
| 31 de diciembre de 2025 | $-0.68 | $-0.68 | 0.00% |
| 30 de septiembre de 2025 | $-0.67 | $-0.56 | -0.11% |
| 30 de junio de 2025 | $-0.50 | $-0.58 | 0.08% |
| 31 de marzo de 2025 | $-0.68 | $-0.42 | -0.26% |
| 31 de diciembre de 2024 | $-0.39 | $-0.33 | -0.06% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| BCAX | $953M | -6.7 | — | — | -33.0% | — |
| NTLA | $1.05B | -2.4 | 16.9% | -609.8% | -59.5% | — |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | — |
| FBRX | $353M | -5.8 | 106.6% | -2555.2% | -86.9% | — |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | — |
| TYRA | $1.41B | -13.1 | — | — | -42.7% | — |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | — |
| JBIO | $761M | -4.8 | — | — | -47.7% | — |
| TRAX | — | — | — | — | — | — |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | — |
| ABSI | $529M | -4.2 | -38.2% | -4113.7% | -63.5% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | · | $64M | $31M | |
| SG&A Expense | $31M | $19M | $9M | |
| Operating Expenses | $156M | $82M | $40M | |
| Operating Income | $-156M | $-82M | $-40M | |
| Interest Income | $18M | $15M | $1M | |
| Other Non-op | $18M | $15M | $-12M | |
| Pretax Income | $-138M | $-68M | $-52M | |
| Income Tax | $217.0K | $187.0K | $5.0K | |
| Net Income | $-138M | $-68M | $-52M | |
| EPS (Basic) | $-2.52 | $-4.05 | $-89.61 | |
| EPS (Diluted) | $-2.52 | $-4.05 | $-89.61 | |
| Shares (Basic) | 54,676,896,000 | 16,805,524,000 | 580,109,000 | |
| Shares (Diluted) | 54,676,896,000 | 16,805,524,000 | 580,109,000 | |
| EBITDA | $-156M | $-82M | · |
Balance general 19
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $97M | $490M | $230M | |
| Short-term Investments | $318M | $0 | · | |
| Prepaid Expense | $7M | $13M | $633.0K | |
| Current Assets | $422M | $503M | $231M | |
| PP&E (Net) | $330.0K | $155.0K | $202.0K | |
| Other Non-current Assets | $7M | $7M | $2M | |
| Total Assets | $431M | $510M | $234M | |
| Accrued Liabilities | · | $13M | $8M | |
| Current Liabilities | $29M | $18M | $15M | |
| Capital Leases | $593.0K | $131.0K | $372.0K | |
| Other Non-current Liabilities | · | $0 | $17.0K | |
| Total Liabilities | $30M | $18M | $15M | |
| Common Stock | $7.0K | $7.0K | $2.0K | |
| Paid-in Capital | $760M | $713M | $4M | |
| Retained Earnings | $-359M | $-221M | $-153M | |
| AOCI | $243.0K | $0 | · | |
| Stockholders' Equity | $401M | $492M | $-149M | |
| Liabilities + Equity | $431M | $510M | $234M | |
| Shares Outstanding | 56,600,724 | 54,440,013 | 640,386 |
Flujo de Efectivo 10
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $15M | $7M | $2M | |
| Deferred Tax | $0 | $0 | $0 | |
| Operating Cash Flow | $-107M | $-75M | $-46M | |
| CapEx | $280.0K | $71.0K | $586.0K | |
| Investing Cash Flow | $-318M | $-9.0K | $-586.0K | |
| Stock Issued | $29M | $332M | $0 | |
| Net Stock Activity | $29M | $332M | · | |
| Financing Cash Flow | $32M | $334M | $272M | |
| Net Change in Cash | $-393M | $259M | $226M | |
| Free Cash Flow | $-107M | $-75M | · |
Rentabilidad 3
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -29.3% | -18.3% | · | |
| ROE | -33.0% | -13.6% | · | |
| ROIC | -38.8% | -16.8% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 14.6 | 27.9 | · | |
| Quick Ratio | 14.3 | 27.2 | · |
Valoración (TTM) 8
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-138M | $-68M | · | |
| Market Cap | $953M | $948M | · | |
| P/E | -6.7 | -4.3 | · | |
| P/B | 2.4 | 1.9 | · | |
| P / Tangible Book | 2.4 | 1.9 | · | |
| P / Cash Flow | -8.9 | -12.7 | · | |
| P / FCF | -8.9 | -12.7 | · | |
| Earnings Yield | -15.0% | -23.2% | · |
Estado de resultados 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | $33M | $25M | $34M | · | $16M | $16M | $12M | $10M | |
| SG&A Expense | $14M | $13M | $8M | $8M | $7M | $7M | $7M | $5M | $4M | $3M | $3M | |
| Operating Expenses | $60M | $60M | $41M | $41M | $32M | $42M | $27M | $21M | $20M | $15M | $14M | |
| Operating Income | $-60M | $-60M | $-41M | $-41M | $-32M | $-42M | $-27M | $-21M | $-20M | $-15M | $-14M | |
| Interest Income | $5M | $4M | $4M | $4M | $5M | $5M | $6M | $3M | $3M | $3M | $1M | |
| Other Non-op | $5M | $4M | $4M | $4M | $5M | $5M | $6M | $3M | $3M | $3M | $1M | |
| Pretax Income | $-55M | $-56M | $-37M | $-36M | $-27M | $-37M | $-21M | $-17M | $-17M | $-13M | $-12M | |
| Income Tax | $61.0K | $52.0K | $53.0K | $40.0K | $52.0K | $72.0K | $186.0K | $0 | $0 | $1.0K | $5.0K | |
| Net Income | $-55M | $-56M | $-37M | $-36M | $-27M | $-37M | $-21M | $-17M | $-17M | $-13M | $-12M | |
| EPS (Basic) | $-0.82 | $-0.93 | $-0.67 | $-0.67 | $-0.50 | $-0.68 | $35.50 | $-1.60 | $-19.01 | $-18.94 | $-19.43 | |
| EPS (Diluted) | $-0.82 | $-0.93 | $-0.67 | $-0.67 | $-0.50 | $-0.68 | $35.50 | $-1.60 | $-19.01 | $-18.94 | $-19.43 | |
| Shares (Basic) | 67,925,963 | 60,717,041 | 54,513,336,391 | 54,563,864 | 54,539,230 | 54,456,515 | 16,793,065,830 | 10,901,138 | 896,744 | 660,288 | 579,545,517 | |
| Shares (Diluted) | 67,925,963 | 60,717,041 | 54,513,336,391 | 54,563,864 | 54,539,230 | 54,456,515 | 16,793,065,830 | 10,901,138 | 896,744 | 660,288 | 579,545,517 | |
| EBITDA | $-60M | $-60M | · | $-41M | $-32M | $-42M | · | $-21M | · | · | · |
Balance general 19
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $97M | $323M | $97M | $172M | $437M | $462M | $490M | $521M | · | · | $230M | |
| Short-term Investments | $401M | $216M | $318M | $118M | · | · | $0 | · | · | · | · | |
| Prepaid Expense | $7M | $5M | $7M | $7M | $8M | $9M | $13M | $756.0K | · | · | $633.0K | |
| Current Assets | $504M | $545M | $422M | $297M | $444M | $471M | $503M | $522M | · | · | $231M | |
| PP&E (Net) | $362.0K | $346.0K | $330.0K | $135.0K | $117.0K | $136.0K | $155.0K | $130.0K | · | · | $202.0K | |
| Other Non-current Assets | $7M | $7M | $7M | $8M | $7M | $7M | $7M | $2M | · | · | $2M | |
| Total Assets | $512M | $554M | $431M | $425M | $454M | $478M | $510M | $524M | · | · | $234M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | $8M | |
| Current Liabilities | $43M | $39M | $29M | $21M | $17M | $19M | $18M | $14M | · | · | $15M | |
| Capital Leases | $0 | $301.0K | $593.0K | $880.0K | $1M | $0 | $131.0K | $137.0K | · | · | $372.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | · | · | $17.0K | |
| Total Liabilities | $43M | $40M | $30M | $22M | $18M | $19M | $18M | $15M | · | · | $15M | |
| Common Stock | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | · | · | $2.0K | |
| Paid-in Capital | $940M | $929M | $760M | $724M | $720M | $717M | $713M | $710M | · | · | $4M | |
| Retained Earnings | $-471M | $-415M | $-359M | $-322M | $-285M | $-258M | $-221M | $-200M | · | · | $-153M | |
| AOCI | $-567.0K | $-243.0K | $243.0K | $-136.0K | · | · | $0 | · | · | · | · | |
| Stockholders' Equity | $469M | $514M | $401M | $403M | $435M | $459M | $492M | $510M | · | · | $-149M | |
| Liabilities + Equity | $512M | $554M | $431M | $425M | $454M | $478M | $510M | $524M | · | · | $234M | |
| Shares Outstanding | 65,931,128 | 65,547,037 | 56,600,724 | 54,612,477 | 54,556,078 | 54,528,975 | 54,440,013 | 54,409,708 | · | · | 640,386 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $6M | $4M | $4M | $3M | $3M | $3M | $2M | $1M | $1M | $765.0K | |
| Operating Cash Flow | $-44M | $-38M | $-24M | $-29M | $-26M | $-28M | $-30M | $-17M | $-13M | $-15M | $-8M | |
| CapEx | $60.0K | $60.0K | $238.0K | $42.0K | $0 | $0 | $40.0K | $8.0K | $19.0K | $4.0K | $436.0K | |
| Investing Cash Flow | $-185M | $101M | $-82M | $-236M | $0 | $0 | $-40.0K | $-8.0K | $-19.0K | $58.0K | $-436.0K | |
| Stock Issued | $0 | $162M | $29M | $0 | $0 | $0 | $-1M | · | · | · | $0 | |
| Net Stock Activity | · | $162M | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $163M | $31M | $436.0K | $135.0K | $460.0K | $-975.0K | $334M | $734.0K | $137.0K | $195M | |
| Net Change in Cash | $-227M | $227M | $-75M | $-265M | $-25M | $-28M | $-31M | $317M | $-12M | $-14M | $186M | |
| Free Cash Flow | · | $-38M | · | · | · | $-28M | · | · | · | · | · |
Rentabilidad 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -11.5% | -10.9% | · | -7.7% | -12.1% | -15.4% | · | -6.7% | · | · | · | |
| ROE | -12.3% | -11.6% | · | -8.0% | -12.6% | -16.1% | · | -6.9% | · | · | · | |
| ROIC | -12.8% | -11.7% | · | -10.1% | -7.4% | -9.1% | · | -4.0% | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.6 | 13.9 | · | 14.1 | 25.8 | 24.6 | · | 36.0 | · | · | · | |
| Quick Ratio | 11.4 | 13.7 | · | 13.8 | 25.3 | 24.2 | · | 36.0 | · | · | · |
Valoración (TTM) 8
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-175M | $-157M | · | $-118M | $-99M | $-84M | · | $-70M | · | · | · | |
| Market Cap | $1.96B | $1.30B | · | $862M | $507M | $711M | · | $1.39B | · | · | · | |
| P/E | -10.2 | -7.2 | · | -4.6 | -0.4 | -0.3 | · | -0.3 | · | · | · | |
| P/B | 4.2 | 2.5 | · | 2.1 | 1.2 | 1.5 | · | 2.7 | · | · | · | |
| P / Tangible Book | 4.2 | 2.5 | · | 2.1 | 1.2 | 1.5 | · | 2.7 | · | · | · | |
| P / Cash Flow | · | -34.8 | · | · | · | -25.3 | · | · | · | · | · | |
| P / FCF | · | -34.7 | · | · | · | -25.3 | · | · | · | · | · | |
| Earnings Yield | -9.8% | -14.0% | · | -21.9% | -234.5% | -308.8% | · | -305.4% | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Beneficio neto | $-138M | $-68M | $-52M |
| EPS Diluido | $-2.52 | $-4.05 | $-89.61 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ratio corriente | 14.6 | 27.9 | — |
| Ratio Rápido | 14.3 | 27.2 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flujo de caja libre | $-107M | $-75M | — |
Últimas noticias Noticias recientes que mencionan a esta empresa
- What Does the Bicara Therapeutics CEO's Sale of 15,000 Shares Mean for Investors?
- Bicara Stock sube un 50%, y un inversor en biotecnología lo ha convertido en una apuesta del 29% de su cartera
- El CEO de Bicara Therapeutics Vendió Más de 8,000 Acciones de la Compañía. ¿Es la Acción una Venta o una Compra?
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 186 declarantes · $1.6B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 48 (+21 vs trimestre anterior) | 9 (-11 vs trimestre anterior) | 58 (+6 vs trimestre anterior) | 42 (-1 vs trimestre anterior) | -1.4M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $215 430 432 | 7 255 993 | 13,62% | Acciones |
| Siren, L.L.C. | $166 352 179 | 5 602 970 | 10,51% | Acciones |
| Vestal Point Capital, LP | $155 872 500 | 5 250 000 | 9,85% | Acciones |
| Deep Track Capital, LP | $121 729 000 | 4 100 000 | 7,69% | Acciones |
| RED TREE MANAGEMENT, LLC | $93 924 820 | 3 163 517 | 5,94% | Acciones |
| TPG GP A, LLC | $89 379 518 | 3 010 425 | 5,65% | Acciones |
| JANUS HENDERSON GROUP PLC | $66 105 861 | 3 326 918 | 4,18% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $65 812 012 | 2 216 639 | 4,16% | Acciones |
| STATE STREET CORP | $60 832 435 | 2 048 920 | 3,84% | Acciones |
| Royalty Pharma Sub-Manager, LLC | $60 611 247 | 2 388 150 | 3,83% | Acciones |
| Omega Fund Management, LLC | $54 099 634 | 1 822 150 | 3,42% | Acciones |
| FMR LLC | $32 471 508 | 1 093 685 | 2,05% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $29 715 133 | 1 000 619 | 1,88% | Acciones |
| Jones Hill Capital LP | $26 501 917 | 892 621 | 1,67% | Acciones |
| ACORN CAPITAL ADVISORS, LLC | $19 102 000 | 643 381 | 1,21% | Acciones |
| Aisling Capital Management LP | $16 891 205 | 568 919 | 1,07% | Acciones |
| Palo Alto Investors LP | $16 341 614 | 550 408 | 1,03% | Acciones |
| Rock Springs Capital Management LP | $15 892 641 | 535 286 | 1,00% | Acciones |
| GOLDMAN SACHS GROUP INC | $13 819 003 | 465 443 | 0,87% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $12 820 647 | 431 817 | 0,81% | Acciones |
| NAN FUNG TRINITY (HK) LTD | $12 703 906 | 427 885 | 0,80% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12 437 497 | 418 912 | 0,79% | Acciones |
| Candriam S.C.A. | $11 074 986 | 373 380 | 0,70% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10 851 131 | 365 481 | 0,69% | Acciones |
| Walleye Capital LLC | $10 487 280 | 353 226 | 0,66% | Acciones |
| Ensign Peak Advisors, Inc | $10 160 245 | 342 211 | 0,64% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $9 314 911 | 313 739 | 0,59% | Acciones |
| BANK OF AMERICA CORP /DE/ | $9 063 288 | 305 264 | 0,57% | Acciones |
| Clearbridge Investments, LLC | $8 603 707 | 289 785 | 0,54% | Acciones |
| DAFNA Capital Management LLC | $8 460 314 | 284 955 | 0,53% | Acciones |
| AMERIPRISE FINANCIAL INC | $8 124 509 | 273 642 | 0,51% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $7 786 321 | 262 254 | 0,49% | Acciones |
| TD Asset Management Inc | $7 752 593 | 261 118 | 0,49% | Acciones |
| ALGERT GLOBAL LLC | $6 924 658 | 233 232 | 0,44% | Acciones |
| Woodline Partners LP | $6 908 566 | 232 690 | 0,44% | Acciones |
| SEB Asset Management AB | $6 892 698 | 232 156 | 0,44% | Acciones |
| CITADEL ADVISORS LLC | $6 268 806 | 211 142 | 0,40% | Acciones |
| ORBIMED ADVISORS LLC | $5 673 759 | 191 100 | 0,36% | Acciones |
| Atle Fund Management AB | $4 324 556 | 145 657 | 0,27% | Acciones |
| MORGAN STANLEY | $3 538 068 | 119 167 | 0,22% | Acciones |
| Napean Trading & Investment Co (Singapore) PTE Ltd | $3 378 128 | 113 780 | 0,21% | Acciones |
| Hudson Bay Capital Management LP | $3 117 450 | 105 000 | 0,20% | Acciones |
| Jump Financial, LLC | $2 977 907 | 100 300 | 0,19% | Acciones |
| CITADEL ADVISORS LLC | $2 725 542 | 91 800 | 0,17% | Opción de venta |
| Rhenman & Partners Asset Management AB | $2 617 173 | 88 150 | 0,17% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $2 455 838 | 82 716 | 0,16% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2 142 846 | 72 174 | 0,14% | Acciones |
| MARTINGALE ASSET MANAGEMENT L P | $2 100 390 | 70 744 | 0,13% | Acciones |
| Shay Capital LLC | $2 018 920 | 68 000 | 0,13% | Acciones |
| ALPS ADVISORS INC | $1 964 944 | 66 182 | 0,12% | Acciones |
| UBS Group AG | $1 959 124 | 65 986 | 0,12% | Acciones |
| Quantinno Capital Management LP | $1 899 507 | 63 978 | 0,12% | Acciones |
| SEVEN GRAND MANAGERS, LLC | $1 855 625 | 62 500 | 0,12% | Acciones |
| FIL Ltd | $1 845 946 | 62 174 | 0,12% | Acciones |
| Trexquant Investment LP | $1 758 242 | 59 220 | 0,11% | Acciones |
| Swiss National Bank | $1 757 648 | 59 200 | 0,11% | Acciones |
| XTX Topco Ltd | $1 751 205 | 58 983 | 0,11% | Acciones |
| RHUMBLINE ADVISERS | $1 632 523 | 54 986 | 0,10% | Acciones |
| SCS Capital Management LLC | $1 586 337 | 53 430 | 0,10% | Acciones |
| Mariner, LLC | $1 576 823 | 53 112 | 0,10% | Acciones |
| Burkehill Global Management, LP | $1 484 500 | 50 000 | 0,09% | Acciones |
| CITIGROUP INC | $1 415 916 | 47 690 | 0,09% | Acciones |
| BlackRock, Inc. | $1 398 072 | 47 089 | 0,09% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $1 383 732 | 46 606 | 0,09% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $1 301 728 | 43 844 | 0,08% | Acciones |
| WELLS FARGO & COMPANY/MN | $1 184 423 | 39 893 | 0,07% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $1 147 400 | 38 646 | 0,07% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $1 113 641 | 55 990 | 0,07% | Acciones |
| Corient Private Wealth LP | $1 089 120 | 36 683 | 0,07% | Acciones |
| Bank of New York Mellon Corp | $1 037 101 | 34 931 | 0,07% | Acciones |
| JPMORGAN CHASE & CO | $991 516 | 33 794 | 0,06% | Acciones |
| BARCLAYS PLC | $929 594 | 31 310 | 0,06% | Acciones |
| Rafferty Asset Management, LLC | $904 951 | 30 480 | 0,06% | Acciones |
| Caption Management, LLC | $890 700 | 30 000 | 0,06% | Opción de compra |
| Caption Management, LLC | $890 700 | 30 000 | 0,06% | Opción de venta |
| Bleakley Financial Group, LLC | $866 384 | 29 181 | 0,05% | Acciones |
| Vanguard Global Advisers, LLC | $845 245 | 28 469 | 0,05% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $843 196 | 28 400 | 0,05% | Opción de venta |
| MetLife Investment Management, LLC | $774 553 | 26 088 | 0,05% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $710 868 | 23 943 | 0,04% | Acciones |
| NOMURA HOLDINGS INC | $623 490 | 21 000 | 0,04% | Opción de compra |
| NOMURA HOLDINGS INC | $623 490 | 21 000 | 0,04% | Opción de venta |
| Aquatic Capital Management LLC | $537 805 | 18 114 | 0,03% | Acciones |
| JANE STREET GROUP, LLC | $528 482 | 17 800 | 0,03% | Opción de venta |
| Invesco Ltd. | $516 012 | 17 380 | 0,03% | Acciones |
| Engineers Gate Manager LP | $499 030 | 16 808 | 0,03% | Acciones |
| Russell Investments Group, Ltd. | $479 820 | 16 161 | 0,03% | Acciones |
| Optimize Financial Inc | $477 280 | 23 996 | 0,03% | Acciones |
| PROFUND ADVISORS LLC | $467 321 | 15 740 | 0,03% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $460 195 | 15 500 | 0,03% | Acciones |
| FEDERATED HERMES, INC. | $452 862 | 15 253 | 0,03% | Acciones |
| Virtus Investment Advisers, LLC | $447 903 | 15 086 | 0,03% | Acciones |
| LPL Financial LLC | $435 998 | 14 685 | 0,03% | Acciones |
| Nuveen Asset Management, LLC | $435 988 | 25 028 | 0,03% | Acciones |
| ADAR1 Capital Management, LLC | $406 901 | 13 705 | 0,03% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $388 939 | 13 100 | 0,02% | Opción de compra |
| Police & Firemen's Retirement System of New Jersey | $386 979 | 13 034 | 0,02% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $354 974 | 11 956 | 0,02% | Acciones |
| STATE OF WISCONSIN INVESTMENT BOARD | $351 292 | 11 832 | 0,02% | Acciones |
| Voleon Capital Management LP | $349 184 | 11 761 | 0,02% | Acciones |
Informantes de la empresa 16 insiders · 1 directivos · 9 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Lara Meisner | Chief Legal Officer | 14 de marzo de 2025 M | 0 | 0 | 0 | $0 |
| Jeremy Bender | Consejero | 28 de julio de 2026 A | — | 0 | 0 | $0 |
| Christy J. Oliger | Consejero | 28 de julio de 2026 A | — | 0 | 0 | $0 |
| Kiran Mazumdar-Shaw | Consejero | 9 de junio de 2026 A | — | 0 | 0 | $0 |
| Scott M. Robertson | Consejero | 9 de junio de 2026 A | — | 0 | 0 | $0 |
| Jake Simson | Consejero | 9 de junio de 2026 A | — | 0 | 0 | $0 |
| Kate Haviland | Consejero | 9 de junio de 2026 A | — | 0 | 0 | $0 |
| Christopher Bowden | Consejero | 9 de junio de 2026 A | — | 0 | 0 | $0 |
| Michael Powell | Consejero | 9 de junio de 2026 A | — | 0 | 0 | $0 |
| Nils Lonberg | Consejero | 12 de septiembre de 2024 A | — | 0 | 0 | $0 |
| Jennifer Larson | — | 12 de agosto de 2026 A | — | 0 | 0 | $0 |
| Claire Mazumdar | — | 10 de agosto de 2026 M | 362 152 | 0 | 3 | $-564 035 |
| Ivan Hyep | — | 10 de agosto de 2026 M | 129 855 | 0 | 5 | $-1 345 111 |
| Ryan Cohlhepp | — | 10 de agosto de 2026 M | 181 641 | 0 | 5 | $-1 357 791 |
| FIL Ltd | — | 16 de septiembre de 2024 C | 1 013 853 | 0 | 0 | $0 |
| FMR LLC | — | 16 de septiembre de 2024 C | 1 115 333 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×2 presentaciones | 2 de marzo de 2026 | 11,50% | Enmienda | — | SEC |
| TPG GP A, LLC, David Bonderman, James G. Coulter, Jon Winkelried | 18 de septiembre de 2024 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 39 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,88% | 65 313 NS | 31 de mayo de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,86% | 14 934 NS | 30 de abril de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,17% | 40 903 NS | 30 de abril de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 3 575 SH | 8 de agosto de 2026 | Diario |
| IBB · iShares Trust | 0,08% | 277 172 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,07% | 41 376 SH | 8 de agosto de 2026 | Diario |
| BIB · ProShares Trust | 0,07% | 2 343 NS | 31 de mayo de 2026 | N-PORT |
| IWO · iShares Trust | 0,07% | 347 646 SH | 8 de agosto de 2026 | Diario |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,04% | 53 521 NS | 31 de mayo de 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 25 859 SH | 8 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 254 350 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,04% | 1 126 505 SH | 8 de agosto de 2026 | Diario |
| FSCC · Federated Hermes ETF Trust | 0,03% | 3 402 NS | 31 de mayo de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,02% | 1 482 NS | 31 de mayo de 2026 | N-PORT |
| ISCB · iShares Trust | 0,02% | 1 663 SH | 8 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 16 019 SH | 8 de agosto de 2026 | Diario |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 151 263 NS | 31 de mayo de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 66 932 NS | 30 de abril de 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 1 159 NS | 31 de mayo de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 490 933 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 4 912 SH | 8 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 88 723 SH | 8 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 12 760 NS | 30 de abril de 2026 | N-PORT |
| IWN · iShares Trust | 0,01% | 49 388 SH | 8 de agosto de 2026 | Diario |
| URTY · ProShares Trust | 0,01% | 1 173 NS | 31 de mayo de 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 1 689 SH | 8 de agosto de 2026 | Diario |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 23 032 NS | 31 de mayo de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1 579 NS | 31 de mayo de 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 29 NS | 31 de mayo de 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 12 680 NS | 31 de mayo de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 67 207 SH | 8 de agosto de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 9 434 SH | 8 de agosto de 2026 | Diario |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 24 554 NS | 31 de mayo de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1 521 NS | 30 de abril de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 1 176 NS | 30 de abril de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 3 391 NS | 30 de abril de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 912 NS | 30 de abril de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 676 653 SH | 8 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 692 SH | 8 de agosto de 2026 | Diario |